Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 20/20 | 0.48 |
| ▸ | PIK3CG | P48736 | 6/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.47 |
| ▸ | ABL1 | P00519 | 4/20 | 0.47 |
| ▸ | EGFR | P00533 | 4/20 | 0.47 |
| ▸ | HCK | P08631 | 4/20 | 0.47 |
| ▸ | SRC | P12931 | 4/20 | 0.47 |
| ▸ | KDR | P35968 | 4/20 | 0.47 |
| ▸ | MTOR | P42345 | 4/20 | 0.47 |
| ▸ | EPHB4 | P54760 | 4/20 | 0.47 |
| ▸ | PRKDC | P78527 | 4/20 | 0.47 |
| ▸ | PIK3CB | P42338 | 4/20 | 0.47 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.46 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.46 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22504966 | 0.92 | PIK3CD (0.47) | PIK3CDPIK3CGPIK3CAABL1EGFR | |
| SCHEMBL29641545 | 0.92 | PIK3CD (0.47) | PIK3CDPIK3CGPIK3CAABL1EGFR | |
| SCHEMBL24494698 | 0.85 | PIK3CD (0.48) | PIK3CDPIK3CGPIK3CAABL1EGFR | |
| SCHEMBL16783540 | 0.85 | PIK3CD (0.46) | PIK3CDPIK3CGPIK3CAABL1EGFR | |
| SCHEMBL24494696 | 0.84 | PIK3CD (0.45) | PIK3CDPIK3CGPIK3CAABL1EGFR | |
| SCHEMBL24494708 | 0.83 | PIK3CD (0.43) | PIK3CDPIK3CGABL1SRCPIK3R1 | |
| SCHEMBL22498210 | 0.82 | PIK3CD (0.42) | PIK3CDPIK3CGPIK3CAABL1EGFR | |
| SCHEMBL30679716 | 0.82 | PIK3CD (0.42) | PIK3CDPIK3CGPIK3CAABL1EGFR | |
| SCHEMBL24494672 | 0.80 | PIK3CD (0.45) | PIK3CDPIK3CGPIK3CAABL1EGFR | |
| SCHEMBL21337779 | 0.80 | PIK3CD (0.47) | PIK3CDPIK3CGPIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220175784-A1 | ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220175784-A1 | ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS | PIKFYVE, PDPK1, PIK3R5 | PIK3CD 5/4885PIK3CG 13/4885PIK3CA 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.